Biotechnology News

February 8, 2013

GAINESVILLE & BOCA RATON, Fla.--(BUSINESS WIRE)--Heart Genomics receives loan funding from Institute for Commercialization of Public Research

February 8, 2013

SAN DIEGO--(BUSINESS WIRE)--Critical Diagnostics, makers of the Presage® ST2 Assay, announced today that a six-minute videotape by Antoni Bayes-Genis, MD PhD., head of Cardiology Service at Hospital Germans Trias i Pujol, in Barcelona Spain...

February 8, 2013

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena CEO Maxine Gowen wins 2013 Frank Baldino CEO of the Year Award from PA Bio Organization. Award ceremony on March 13th at Annual Dinner in Philadelphia.

February 8, 2013

PERKASIE, Pa.--(BUSINESS WIRE)--US BioDesign is a global leader in the development and manufacture of biomedical textile structure components for medical devices, introducing non-woven capabilities at MD&M West 2013, booth 3598.

February 8, 2013

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that chairman and CEO Gary Rabin will present at the 15th Annual BIO CEO & Investor...

February 8, 2013

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it has settled all pending litigation with Shire LLC and Shire Laboratories, Inc. (collectively Shire) relating to supply of its authorized generic...

February 8, 2013

ST. PAUL, Minn.--(BUSINESS WIRE)--Analyzing data from RESPECT trial results confirm that patients with a device in place were less likely to suffer another stroke and patients in the medical group experienced larger strokes.

February 8, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Leerink Swann Global Healthcare Conference being held in New York City. Harvey J. Berger, M.D., chairman and chief executive...

February 8, 2013

HAWTHORNE, N.Y. & MUMBAI, India--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) and Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its...

February 8, 2013

WARSAW, Poland--(BUSINESS WIRE)--Recombinant Fc fusion proteins show potential to transform care by providing long-lasting protection from bleeding with fewer injections than the current standard of care

February 8, 2013

HONOLULU--(BUSINESS WIRE)--POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from the combined results of two Phase 3 studies of PA32540, an antiplatelet therapy of...

February 8, 2013

RALEIGH, N.C.--(BUSINESS WIRE)--Health care industry veteran David Hall joins the board of Raleigh, N.C., firm Compass Surgical Partners, an ambulatory surgery center (ASC) management, acquisition and development firm.

February 8, 2013

SAN DIEGO--(BUSINESS WIRE)--Tensys Medical Inc. enters into exclusive distribution relationship with Zhejiang Shanshi for Chinese, Taiwan, Hong Kong markets. Five (5) year agreement worth up to $US 40 million.

February 8, 2013

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended December 31, 2012. Fourth Quarter Results Net earnings were $120.2 million and earnings per diluted...

February 8, 2013

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo announced it has filed a patent infringement lawsuit against Anchen Pharma and Par Pharma related to their ANDA to market a generic version of AMITIZA (lubiprostone)

February 8, 2013

GETINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Press release regarding Getinge’s Capital Markets Day on 8 February The Getinge Group has long performed very well and the company’s strategy for continued profitable growth remains firm. The...

February 8, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: BioGaia (STO:BIOG): (Figures in brackets refer to the same period of last year) 2012 Net sales reached SEK 645.2 (315.0). This figure includes licence revenue of SEK 356.0 million from Nestlé that is...

February 7, 2013

LOS ANGELES--(BUSINESS WIRE)--NEONC Technologies Scientific and Clinical Advisory Board Plans Development and Clinical
Intranasal Testing of NEO100 in Treatment of Gliomas

February 7, 2013

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien today released the results of the Solitaire™ FR Thrombectomy for Acute Revascularization (STAR) study.

February 7, 2013

NORCROSS, Ga.--(BUSINESS WIRE)--James Czirr, Executive Chairman of Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, will be a guest on “The RedChip Money...

February 7, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, AMAG’s chief executive officer, will participate in the Leerink Swann Global Healthcare Conference on Wednesday, February 13, 2013...

February 7, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) will release its fourth quarter and full year 2012 financial results on Thursday, February 21, 2013 after the markets close. The announcement will be followed by a live...

February 7, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year 2012, and company highlights. “2012 was a...

February 7, 2013

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) (“the Company” or “RegeneRx”) today announced that it has received a Notice of Allowance of a Chinese patent application for uses of Thymosin beta 4 (TB4) for treating...

February 7, 2013

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced the release of the third annual thought leadership white paper, 2012 European Trends in Aggregate Spend, Transparency and Disclosure, which analyzes insights from European...

February 7, 2013

BRIDGEWATER, N.J.--(BUSINESS WIRE)--CorMedix Inc. (“CorMedix”) (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announces the...

February 7, 2013

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics today announced it has priced an offering of shares of its common stock and warrants to purchase common stock in a private registered offering for gross proceeds of $3,250,000.

February 7, 2013

IRVINE, Calif. & MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan”) and MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) (“MAP”) today announced that the Federal Trade Commission has granted early termination of the...

February 7, 2013

NEW YORK--(BUSINESS WIRE)--Dan Doctoroff, Bloomberg LP CEO and president; David Rubenstein, co-CEO of The Carlyle Group; and Bloomberg Philanthropies Unveil Target ALS.

February 7, 2013

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) today announced that President and CEO Gajus Worthington will present at the Leerink Swann 2013 Global Healthcare Conference on February 14, 2013, at 11:00 a.m. EST...

February 7, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--Avanir successfully completed the first of a two-stage pharmacokinetic study in healthy subjects with AVP-786.

February 7, 2013

NEW YORK--(BUSINESS WIRE)--Deerfield announces financing transaction with Flamel Technologies

February 7, 2013

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces the Presentation of Lymphoseek® Data at Upcoming Scientific Meetings

February 7, 2013

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics announced that Neil K. Warma, President and Chief Executive Officer, will present at the 15th Annual BIO CEO & Investor Conference in New York City on Monday, February 11, 2013.

February 7, 2013

NEW YORK--(BUSINESS WIRE)--Medidata Solutions announced that it will release its fourth quarter 2012 financial results before the open of the market on Thursday, February 21, 2013 on an 8 am call.

February 7, 2013

WOBURN, Mass.--(BUSINESS WIRE)--ArQule will present at the 2013 Leerink Swann Global Healthcare Conference.

February 7, 2013

MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, has appointed Mohan Gopalkrishnan as Vice President - Operations. Mr. Gopalkrishnan will be responsible for managing ERBA Diagnostics...

February 7, 2013

ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics Inc. (RTI) (Nasdaq:RTIX), a leading provider of orthopedic and other biologic implants, reported operating results for the fourth quarter and full year of 2012 as follows: Quarterly Highlights:...

February 7, 2013

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) announced that Geert Kersten, Chief Executive Officer, will be presenting at the 2013 BIO CEO & Investor Conference on Monday, February 11, 2013 at 11:00 a.m. The conference...

February 7, 2013

NASHUA, N.H.--(BUSINESS WIRE)--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company...

February 7, 2013

INDIANAPOLIS--(BUSINESS WIRE)--Results from dozens of studies during the past two years indicate a program approach including Enlist Duo herbicide with Colex-D Technology will provide greater than 95 percent control of tough weeds.

February 7, 2013

PERKASIE, Pa.--(BUSINESS WIRE)--Secant Medical® has named Jacqueline Ferro as vice president of quality and regulatory assurance.

February 7, 2013

PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis will present at BIO CEO

February 7, 2013

BURLINGTON, Mass. & HONG KONG--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX), a developer of novel biotherapeutics for unmet medical needs, and CVie Therapeutics (CVie), a subsidiary of Lee’s Pharmaceutical Holdings Ltd., announced today a...

February 7, 2013

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (NASDAQ: GTXI) today announced that it will host a conference call and webcast to provide a corporate update and discuss the Company's fourth quarter and full year 2012 financial results on Thursday,...

February 7, 2013

LONDON--(BUSINESS WIRE)--New market research report “MediPoint: Bioabsorbable Stents - US Analysis and Market Forecast” drawn up by GlobalData has been recently published at MarketPublishers.com